General Information of DTT (ID: TTLP6GN)

DTT Name Bacterial DD-carboxypeptidase (Bact vanYB) DTT Info
UniProt ID
VANY_ENTFA
Gene Name Bact vanYB

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Investigative Drug(s)
Approved Drug(s)
Clinical Trial Drug(s)
4 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
B-Lactams DMR8YD6 Bacterial infection 1A00-1C4Z Approved [1]
Cefalotin DMVYSLE Bacterial infection 1A00-1C4Z Approved [2]
Cefotaxime DMMKHBJ Bacterial infection 1A00-1C4Z Approved [3], [2]
Cephalosporin DM79XDW Bacterial infection 1A00-1C4Z Approved [4]
------------------------------------------------------------------------------------
1 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
TD-1792 DMGKBZH Skin infection 1F28-1G0Z Phase 3 [5]
------------------------------------------------------------------------------------
10 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
2-[(Dioxidophosphino)Oxy]Benzoate DMVSI6R Discovery agent N.A. Investigative [6]
3-boronobenzoic acid DMRCJW0 Discovery agent N.A. Investigative [7]
5-boronothiophene-2-carboxylic acid DMPITR9 Discovery agent N.A. Investigative [7]
Benzo[c][1,2]oxaborol-1(3H)-ol DMZR02J Discovery agent N.A. Investigative [7]
Cephalosporin C DMYW3ZG Discovery agent N.A. Investigative [8]
D-alanine DMVIDQL Discovery agent N.A. Investigative [6]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [6]
Glycyl-L-Alpha-Amino-Epsilon-Pimelyl-D-Alanine DM8FTJN Discovery agent N.A. Investigative [6]
NITROCEFIN DM7M5VY Discovery agent N.A. Investigative [9]
Phenyl Boronic acid DMFZH49 Discovery agent N.A. Investigative [7]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Investigative Drug(s)
Molecule Interaction Atlas

References

1 Has nature already identified all useful antibacterial targets Curr Opin Microbiol. 2008 Oct;11(5):387-92.
2 Binding of cephalothin and cefotaxime to D-ala-D-ala-peptidase reveals a functional basis of a natural mutation in a low-affinity penicillin-binding protein and in extended-spectrum beta-lactamases. Biochemistry. 1995 Jul 25;34(29):9532-40.
3 Extended-spectrum cephalosporinases: structure, detection and epidemiology. Future Microbiol. 2007 Jun;2:297-307.
4 A 1.2-A snapshot of the final step of bacterial cell wall biosynthesis. Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1427-31.
5 How many modes of action should an antibiotic have Curr Opin Pharmacol. 2008 Oct;8(5):564-73.
6 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
7 Synthesis and evaluation of 3-(dihydroxyboryl)benzoic acids as D,D-carboxypeptidase R39 inhibitors. J Med Chem. 2009 Oct 8;52(19):6097-106.
8 DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41.
9 The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.